Xiangmei M. Zhang

Hebei Provincial Key Laboratory Of Tumor Microenvironment And Drug Resistance
Shijiazhuang, 050017, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment.

Tumor-Infiltrating Mast Cells Enhance Neoadjuvant Therapy Efficacy in ESCC via Modulation of the Desmoplastic Microenvironment.

Journal: OncoTargets and therapy

Published: August 29, 2025

Intratumoral microbiota exhibiting varied responses to neoadjuvant chemotherapy in triple-negative breast cancer revealed by 2bRAD-M.

Intratumoral microbiota exhibiting varied responses to neoadjuvant chemotherapy in triple-negative breast cancer revealed by 2bRAD-M.

Journal: Journal of translational medicine

Published: August 07, 2025

Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis.

Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis.

Journal: Cancer biology & therapy

Published: December 20, 2024

Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancer.

Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancer.

Journal: Oncology research

Published: November 29, 2024

JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway.

JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway.

Journal: Expert review of anticancer therapy

Published: September 10, 2024

Improved Efficacy of Triple-Negative Breast Cancer Immunotherapy via Hydrogel-Based Co-Delivery of CAR-T Cells and Mitophagy Agonist.

Improved Efficacy of Triple-Negative Breast Cancer Immunotherapy via Hydrogel-Based Co-Delivery of CAR-T Cells and Mitophagy Agonist.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 18, 2024

IFIH1 promotes apoptosis through the TBK1/IRF3 pathway in triple-negative breast cancer.

IFIH1 promotes apoptosis through the TBK1/IRF3 pathway in triple-negative breast cancer.

Journal: Neoplasma

Published: June 14, 2024

Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2- breast cancer: a propensity score-matched retrospective cohort study using the SEER database.

Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2- breast cancer: a propensity score-matched retrospective cohort study using the SEER database.

Journal: BMJ open

Published: March 15, 2024

A bidirectional Mendelian randomization analysis of the causal relationship between inflammatory bowel disease and breast cancer based on estrogen receptor status.

A bidirectional Mendelian randomization analysis of the causal relationship between inflammatory bowel disease and breast cancer based on estrogen receptor status.

Journal: Discover oncology

Published: November 14, 2023

Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment.

Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment.

Journal: Medicine

Published: September 29, 2023

Quantifying the contributions of natural and anthropogenic dust sources in Shanxi Province, northern China.

Quantifying the contributions of natural and anthropogenic dust sources in Shanxi Province, northern China.

Journal: Chemosphere

Published: July 18, 2023

Relationship between oily fish intake and breast cancer based on estrogen receptor status: a Mendelian randomization study.

Relationship between oily fish intake and breast cancer based on estrogen receptor status: a Mendelian randomization study.

Journal: Breast cancer research and treatment

Published: July 18, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026